Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Geriatric Oncology].
Maeno S, Nagashima F, Naruge D, Okano N, Kawai K, Kobayashi T, Kitamura H, Furuse J. Maeno S, et al. Among authors: kobayashi t. Gan To Kagaku Ryoho. 2017 Feb;44(2):97-101. Gan To Kagaku Ryoho. 2017. PMID: 28223666 Review. Japanese.
[The Risk Factors of Cancer Chemotherapy in Elderly Patients].
Nozaki E, Maeno S, Nagashima F, Okano N, Kawai K, Kobayashi T, Yamauchi Y, Furuse J. Nozaki E, et al. Among authors: kobayashi t. Gan To Kagaku Ryoho. 2018 Jan;45(1):8-11. Gan To Kagaku Ryoho. 2018. PMID: 29362297 Japanese.
Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms.
Yokokawa A, Kaneko S, Endo S, Minowa Y, Ayukawa H, Hirano R, Nagashima F, Naruge D, Okano N, Kobayashi T, Kawai K, Furuse J, Furuta T, Shibasaki H. Yokokawa A, et al. Among authors: kobayashi t. Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):317-324. doi: 10.1007/s13318-021-00675-3. Epub 2021 Feb 23. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33619631
Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trial.
Ohba A, Ueno H, Shiba S, Okano N, Kobayashi T, Nagashima F, Sasahira N, Sasaki M, Imaoka H, Sakamoto Y, Kondo S, Morizane C, Ozaka M, Ikeda M, Furuse J, Okusaka T. Ohba A, et al. Among authors: kobayashi t. Eur J Cancer. 2022 Oct;174:40-47. doi: 10.1016/j.ejca.2022.06.010. Epub 2022 Aug 12. Eur J Cancer. 2022. PMID: 35970035 Clinical Trial.
14,524 results
You have reached the last available page of results. Please see the User Guide for more information.